Drug name - Nuvigil

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7132570 CEPHALON Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
Dec, 2023

(1 year, 3 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297346 CEPHALON Pharmaceutical formulations of modafinil Nov, 2023

(1 year, 3 months from now)

US7297346

(Pediatric)

CEPHALON Pharmaceutical formulations of modafinil May, 2024

(1 year, 9 months from now)

US7132570

(Pediatric)

CEPHALON Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil Jun, 2024

(1 year, 9 months from now)

More Information on Dosage
Strength Dosage Availability
50MG TABLET;ORAL Prescription
100MG TABLET;ORAL Discontinued
150MG TABLET;ORAL Prescription
200MG TABLET;ORAL Prescription
250MG TABLET;ORAL Prescription